Glooko Announces Digital Health Collaboration with Eli Lilly's Connected Insulin Pen Solutions in Global Markets
Glooko Announces Digital Health Collaboration with Eli Lilly's Connected Insulin Pen Solutions in Global Markets News provided by Share this article Share this article GOTHENBURG, Sweden, May 6, 2021 /PRNewswire/ -- Glooko Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions, today announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly's connected insulin pen solutions. The technology collaboration will ease insulin management for people with diabetes and their healthcar...